1.Division of Immunotherapy,Research Center Borstel,Borstel,Germany;2.LIONEX Diagnostics & Therapeutics GmbH,Braunschweig,Germany;3.Helios Agnes Karll Hospital,Bad Schwartau,Germany
Abstract:
Background
Bacillus Calmette Guérin (BCG)-immunotherapy has a well-documented and successful clinical history in the treatment of bladder cancer. However, regularly observed side effects, a certain degree of nonresponders and restriction to superficial cancers remain a major obstacle. Therefore, alternative treatment strategies are intensively being explored.